Search bioRxivSearch

Biology subjects

de la Villa, P.

Publications and source records attributed to de la Villa, P..

2 recordsLinked to original sources

Nr2e3 functional domain ablation by CRISPR-Cas9D10A identifies a new isoform and generates Retinitis Pigmentosa and Enhanced S-cone Syndrome models

Mutations in NR2E3 cause retinitis pigmentosa (RP) and enhanced S-cone syndrome (ESCS) in humans. This gene produces a large isoform encoded in 8 exons and a previously unreported shorter isoform of 7 exons, whose function is unknown. We generated two mouse models by targeting exon 8 of Nr2e3 using CRISPR/Cas9-D10A nickase. Allele {Delta}27 is an in-frame deletion of 27 bp that ablates the dimerization domain, whereas allele {Delta}E8 (full deletion of exon 8), produces only the short isoform that lacks the dimerization and repressor domains. The {Delta}27 mutant shows developmental alterations and a non-progressive electrophysiological dysfunction that resembles the ESCS phenotype. The {Delta}E8 mutant exhibits progressive retinal degeneration, as occurs in human RP patients. Interestingly, the mutant retinas show invaginations similar to fovea-like pits. Our mutants suggest a role of Nr2e3 as a cone-patterning regulator and provide valuable models for studying mechanisms of NR2E3-associated retinal dystrophies and evaluating potential therapies. O_FIG O_LINKSMALLFIG WIDTH=186 HEIGHT=200 SRC="FIGDIR/small/147785v1_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@1f5916forg.highwire.dtl.DTLVardef@11f1384org.highwire.dtl.DTLVardef@13a6cd2org.highwire.dtl.DTLVardef@be52b3_HPS_FORMAT_FIGEXP M_FIG C_FIG Highlights- Nr2e3 mouse models were generated by exon 8 deletion using CRISPR/Cas9 D10A nickase. - New Nr2e3 mRNA retaining intron 7 encodes a short protein expressed in adult retina. - Deletion of 9 aa of the NR2E3 dimerization domain causes enhanced S-cone syndrome. - Deletion of exon 8 produces a phenotype similar to Retinitis Pigmentosa in mouse.

genetics

Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa

Synaptic loss, neuronal death, and circuit remodeling are common features of central nervous system neurodegenerative disorders. Retinitis pigmentosa (RP), the leading cause of inherited blindness, is a group of retinal dystrophies characterized by photoreceptor dysfunction and death. The insulin receptor, a key controller of metabolism, also regulates neuronal survival and synaptic formation, maintenance, and activity. Indeed, deficient insulin receptor signaling has been implicated in several brain neurodegenerative pathologies. We present evidence linking impaired insulin receptor signaling with RP. We describe a selective decrease in the levels of the insulin receptor and its downstream effector phospho-S6 in retinal horizontal cell axons in the rd10 mouse model of RP, as well as aberrant synapses between rod photoreceptors and the postsynaptic terminals of horizontal and bipolar cells. A gene therapy strategy to induce sustained proinsulin production restored retinal insulin receptor signaling, by increasing S6 phosphorylation, without peripheral metabolic consequences. Moreover, proinsulin preserved photoreceptor synaptic connectivity and prolonged visual function in electroretinogram and optomotor tests. These findings support the therapeutic potential of proinsulin in RP.

neuroscience